|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: AMPERSAND MEDICAL CORP, 10-Q, EX-10.20, 2000-11-14 |
Next: NSTOR TECHNOLOGIES INC, 10-Q, 2000-11-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary information extracted from the Ampersand Medical
Corporation Consolidated Balance Sheet (Unaudited) for September 30, 2000 and
the Consolidated Statement of Operations (Unaudited) for the Nine-Months ended
September 30, 2000 and is qualifed in its entirety by reference to such
financial statements.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> SEP-30-2000
<CASH> 21
<SECURITIES> 0
<RECEIVABLES> 517
<ALLOWANCES> 22
<INVENTORY> 159
<CURRENT-ASSETS> 2091
<PP&E> 451
<DEPRECIATION> 109
<TOTAL-ASSETS> 5327
<CURRENT-LIABILITIES> 2623
<BONDS> 0
30
0
<COMMON> 0
<OTHER-SE> 13095
<TOTAL-LIABILITY-AND-EQUITY> 5327
<SALES> 839
<TOTAL-REVENUES> 839
<CGS> 543
<TOTAL-COSTS> 543
<OTHER-EXPENSES> 5769
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 65
<INCOME-PRETAX> (5260)
<INCOME-TAX> 0
<INCOME-CONTINUING> (5260)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (5260)
<EPS-BASIC> (0.19)
<EPS-DILUTED> (0.19)
</TABLE>
|
|